The capabilities of imaging technologies, fluorescent sensors, and optogenetics tools for cell biology are advancing. In parallel, cellular reprogramming and organoid engineering are expanding the use of human neuronal models in vitro. This creates an increasing need for tissue culture conditions better adapted to live-cell imaging. Here, we identify multiple caveats of traditional media when used for live imaging and functional assays on neuronal cultures (i.e., suboptimal fluorescence signals, phototoxicity, and unphysiological neuronal activity). To overcome these issues, we develop a neuromedium called BrainPhys™ Imaging (BPI) in which we optimize the concentrations of fluorescent and phototoxic compounds. BPI is based on the formulation of the original BrainPhys medium. We benchmark available neuronal media and show that BPI enhances fluorescence signals, reduces phototoxicity and optimally supports the electrical and synaptic activity of neurons in culture. We also show the superior capacity of BPI for optogenetics and calcium imaging of human neurons. Altogether, our study shows that BPI improves the quality of a wide range of fluorescence imaging applications with live neurons in vitro while supporting optimal neuronal viability and function.
For many years, light microscopy was restricted to anatomical and cellular morphology analysis. In the last two decades, technological advances in fluorescent probes, optogenetics, camera sensors, light-emitting diodes, and microscopes have unleashed the capacity of light microscopy for functional imaging1,2,3,4,5,6,7. For example, calcium imaging is an increasingly popular electrophysiological assay8 and neuroscientists are slowly replacing laborious patch-clamping experiments with optical voltage sensors6,9,10. Precise light-emitting molecular pH sensors provide insights into synaptic or lysosomal mechanisms. At the same time, light has also become a powerful tool to remotely control the function of neurons. Optogenetics allow precise activation and inhibition of subtypes of neurons7,11,12. The design of photoreleasable caged molecules advances our understanding of molecular physiology13,14,15. However, unintended light-induced cytotoxicity with live-cell imaging technologies in vitro may hinder scientific discoveries16. Limiting the intensity and duration of light exposure or using longer wavelengths (>500 nm) may partially reduce live imaging-induced cytotoxicity17,18,19,20. However, it does not resolve the issue and comes at the cost of sub-optimal signal-to-background ratios.
Neuronal cultures are notoriously difficult to maintain and have a low tolerance for manipulation and stress. The most likely cause of light-induced toxicity is the generation of reactive oxygen species produced by light-reactive components in the media21,22,23. Previous studies have shown that adjusting phosphate buffers such as N-(2-hydroxyethyl)piperazine-N′-2-ethane sulfonic acid (HEPES), may reduce the accumulation of light-induced cytotoxic products in tissue culture media24; further removing riboflavin from Neurobasal™-based and DMEM-based media improved rat primary neuronal cell survival when exposed to blue light (470 nm)25. These base media optimized for phototoxicity may help with some imaging experiments. However, we found that with human neuronal models, DMEM and neurobasal are suboptimal for the firing of action potentials and synaptic activity (glutamatergic and GABAergic), which is a major caveat to modelling the physiology of the human brain in vitro26.
Thus, there is a need for a neuronal medium specialized for functional imaging experiments. Such a medium needs to support neurophysiological activity, minimize light-induced toxicity, and enhance fluorescent signal-to-background ratios. To address this need, we implemented the formulation of the original BrainPhys™ (BP) medium26 in the design of a functional imaging neuromedium, which we called BrainPhys™ Imaging (BPI). We benchmarked its performance in comparison with other media currently available. We found that removing the light-reactive components from BP enhanced fluorescent signals and reduced neuronal phototoxicity. We demonstrated that the BPI formula could be used to culture neurons without a detrimental effect on cell survival, and its osmolality matches physiological levels of human CSF. Finally, we used patch-clamping, multielectrode arrays, calcium imaging, and optogenetics to show that the formulation of BrainPhys™ Imaging supports optimal electrophysiological functions of human neurons in vitro.
Adjustment of standard BrainPhys basal medium formula to optimize live-cell imaging
To optimize the original BrainPhys basal medium for imaging, we adjusted the components within the formulation which we identified as potentially increasing fluorescent background noise and phototoxicity. The major changes made were the removal of phenol red, and adjustments of the vitamins (e.g., riboflavin) and pH buffers. The vitamin content of the medium appeared as the main factor responsible for phototoxicity and autofluorescence interference at excitation wavelengths less than 500 nm. The adjustments made had no significant effect on the overall osmolality of the medium (Fig. 1a). This is an essential attribute of BrainPhys that we wished to maintain as it is similar to that of human cerebrospinal fluid (∼300 mOsmol/L). We also confirmed that the osmolality of media conditioned with hiPSC-derived neurons was identical to the fresh media and stable over time (tested for up to 2 weeks, Supplementary Fig. 1a). The pH was also maintained at physiological levels (pH 7.4) in the BPI formulation. The formulation is referred to as BrainPhys Imaging (BPI). For comparison, we also evaluated two other commercially available imaging media, BrightCell™ NEUMO and FluoroBrite™ DMEM, which were previously modified based on Neurobasal and DMEM, respectively25. We previously demonstrated that the more physiological composition of BrainPhys basal medium improves the electrophysiology and synaptic activity of human neurons in vitro in comparison to DMEM and Neurobasal26. In the present study, we compared the imaging performance, phototoxicity, and electrophysiological properties of cells in BPI to standard neuronal media and other imaging media currently available.
BPI minimizes absorbance and autofluorescence across the visible light spectrum
We compared the performance for fluorescence imaging of BPI to other tissue culture media (Figs. 1 and Fig. 2). First, we measured the absorbance spectrum (300–800 nm) of BPI basal and other basal media without supplements (Fig. 1b). The absorbance above 600 nm was close to zero for all media tested. However, below 600 nm the relative level of absorbance differed between basal media. All classical basal media used for neuronal culture (standard BrainPhys, Neurobasal, and DMEM/F12) had relatively high absorbance for all wavelengths below 600 nm. Removing phenol red from standard media helped to reduce the absorbance between 400 and 600 nm. Further adjustment of vitamins and pH buffer in BPI also helped to reduce the absorbance below 400 nm to levels almost as low as PBS. We also confirmed that the addition to the basal medium of a range of supplements (SM1, N2-A, BDNF, GDNF, Ascorbic Acid, cAMP, Laminin; selection based on the standard BrainPhys formulation established in ref. 26) did not increase the absorbance above 300 nm (Fig. 1b).
Then, we measured the relative autofluorescence of each media in the absence of cells (Fig. 1c–f). We used a custom-made bifurcated fiber probe that we positioned within the media. We then excited each medium at four wavelengths sequentially from violet to green (375, 405, 488, and 532 nm) and measured the emission spectra from 400 to 700 nm. We found that BPI basal medium autofluorescence across the visible light spectrum was as low as for PBS (Fig. 1c). In contrast, all other standard media tested (BP, DMEM, Neurobasal) showed much higher autofluorescence signals at excitation wavelengths from violet to green. When tested with short wavelengths light excitation (375 and 405 nm), BPI also showed slightly lower autofluorescence than NEUMO and FluoroBrite (Fig. 1c). Low autofluorescence of BPI across the light spectrum was maintained despite adding supplements. For further statistical comparison, we repeated these experiments using a plate reader (Fig. 1d–f). We compared the mean fluorescence intensity with three dichroic filters: blue (excitation/emission at 355/460 nm), green (excitation/emission at 485/520 nm), and red (excitation/emission at 544/590 nm). The blue, green, and red autofluorescence levels of BPI were significantly lower than that of any other standard basal neuromedia (BrainPhys, DMEM, Neurobasal) (Fig. 1d–f). At shorter wavelengths (blue and green), BPI also outperformed the autofluorescence of other specialized imaging media (BrightCell™ NEUMO and FluoroBrite™ DMEM) (Fig. 1d, e). At longer wavelengths (red), the autofluorescence of BPI and other imaging media was similar (Fig. 1f). The green and red autofluorescence of BPI was equivalent to that of PBS and H2O (Fig. 1e, f). However, we noted that the blue autofluorescence in BPI remained slightly higher than PBS or H2O, despite outperforming all the other media (Fig. 1d). The removal of phenol red alone did not show any reduction in autofluorescence in the blue and green channels, but helped to lower the red autofluorescence (Fig. 1d–f). Autofluorescence with light excitation at a longer wavelength (532 nm) was relatively low for all media tested (Fig. 1c), though the plate reader experiments revealed a relatively small but significant reduction in autofluorescence for BPI compared to standard media in the red channel (Fig. 1f). Overall, the absorbance and autofluorescence of BPI were most distinctively reduced for excitation wavelengths between ultraviolet and blue compared to other neuronal media (Fig. 1b, c). Most importantly, the modifications made in BPI lowered the absorbance and autofluorescence at levels similar to PBS across all visible wavelengths.
BPI improves fluorescent signal-to-background ratios
We then showed that the lower level of autofluorescence of BPI enhanced signal-to-background ratios, when imaging brain cells in vitro, using healthy human iPSC-derived neurons in monolayers (Fig. 2a–c and Supplementary Figs. 2, 3) and organoids (Fig. 2d) or rat primary cortical neurons (Fig. 2e–f and Supplementary Fig. 1c–f). Live human iPSC-derived neurons were infected with lentivectors to express green (eGFP) using a synapsin promoter (Fig. 2a–c and Supplementary Figs. 2, 3). The human neurons were imaged live in standard BrainPhys or BPI with identical imaging parameters. BPI significantly increased signal-to-background ratios at the neurite and soma regions, and significantly reduced mean background intensities (Fig. 2a–c). When combining analysis at soma and neurite regions, similar increases in signal-to-background ratios were observed. Reperfusing the cells with artificial cerebrospinal fluid (ACSF), after testing them subsequently in BPI and BP, recovered signal-to-background ratios in the background, soma and/or neurite regions to levels identical to BPI (Fig. 2a–c). This confirmed that the effect was not simply due to possible photobleaching. Overall, all the neuronal monolayer and organoid images in BPI showed increased signal-to-background ratios for lower wavelengths (blue and green) compared to all other media tested (standard BrainPhys, Figs. 2a–c, e, f and Supplementary Figs. 1c–f, 2, 3; organoid medium, Fig. 2d; BrainPhys without Phenol Red and NEUMO, Supplementary Fig. 1c–f). The live imaging of an assembly of brain-region specific organoids (assembloids27) in BPI also allowed for better visualization of migrating neurons than in standard organoid maturation medium (Fig. 2d). We then used rat cortical primary neurons to test the signal-to-background ratio at different wavelengths. The primary neurons were either fixed and labeled in red with β-III-tubulin and DyLight™ 594 (excitation/emission at 593/618 nm) or live in green with the neuron-specific dye NeuroFluor™ NeuO (excitation/emission at 468/557 nm). For Hoechst™ 33342 (excitation/emission at 361/497 nm), the neurons were either labeled live or fixed first. For each fluorophore, all images were conducted with identical imaging parameters but in different media (Fig. 2e, f and Supplementary Fig. 1c–f). For longer wavelengths (red), we found no significant improvement in signal-to-background ratio with images taken in BPI (Fig. 2e, f and Supplementary Fig. 1e, f).
Overall our data supports that BPI constitutes an alternative imaging neuronal medium that provides lower absorbance, lower autofluorescence, and enhanced fluorescent signal-to-background ratios throughout the entire light spectrum from ultraviolet (300 nm) to infrared (800 nm), which is used by virtually all fluorophores, sensors and imaging probes in cell biology.
BPI reduces phototoxicity across the light spectrum (from violet to red)
To compare the extent of phototoxicity on neuronal cultures in different media, we first measured the viability of primary rat cortical neurons after prolonged exposure to violet (395–405 nm; 430 Lux ± 3.70 S.E.M), blue (450–475 nm; 14 Lux ± 1.41 S.E.M) and red (620–740 nm; 55 Lux ± 4.99 S.E.M) LED light inside a temperature-controlled incubator (Fig. 3a–d). Neurons exposed to light in phototoxic media exhibited broken neurites and disintegrated cell bodies (Fig. 3a–c and Supplementary Fig. 5); the number of live cells was counted post light-exposure to quantify cell viability. Exposure to violet and blue light caused cell death in standard BrainPhys medium (with or without phenol red) but not in BPI (Fig. 3a–d). We also compared the phototoxicity of the three wavelengths in BPI to NEUMO. Although NEUMO basal is provided with a supplement (SOS), we were unable to sustain healthy neurons with this combination for long enough to perform this assay (Supplementary Fig. 4b). Thus, we tested NEUMO basal medium combined with the same supplement that was added to BrainPhys basal in these experiments (SM1 Neuronal Supplement). In these conditions, NEUMO performed comparably to BPI when stimulated for 12 h with blue light (Fig. 3d). However, when using higher energy violet light (430 Lux ± 3.70 S.E.M) for 6 h, the cells only survived in BPI (Fig. 3d). Red light did not appear phototoxic in any media we tested, even when exposed for longer at four times the Lux intensity of the blue light test (Fig. 3d). To quantify more subtle phototoxic effect preceding cell death, we exposed BP and BPI media to ambient light in the tissue culture hood for 24 h and fed human PSC-derived midbrain and cortical neurons daily for up to 7 days (half media change), while measuring the accumulation of lactate dehydrogenase (LDH) in the supernatant. LDH is a cytosolic enzyme, which is present in neurons and released into the supernatant upon damage to the plasma membrane. We found that media exposure to ambient light triggered a higher release of LDH in cultures fed with BP compared to BPI within two days (Fig. 3e, f). These results were consistent both with cortical and midbrain human neurons (Fig. 3e, f). Riboflavin, which is present in BP and other classical neuromedia, can release free radicals such as hydrogen peroxide (H2O2). We found that H2O2 levels significantly increased in BP after 24 h exposure to ambient light but not in BPI. This H2O2 increase was observed despite adding antioxidants in supplements to both media (Fig. 3g). The spectrum of the ambient light from our tissue culture hood showed multiple-wavelength peaks between 400 and 650 nm (Fig. 3h). Therefore, we used an LED controller instead of ambient light to show that wavelengths around 475 nm (Fig. 3i and Supplementary Fig. 4a) were sufficient to increase the level of H2O2 in BP medium in a dose-dependent manner (Fig. 3j). At the highest dose tested (~105 mW at 475 nm) the level of H2O2 doubled in BP and only slightly increased in BPI. Oxidative stress is also often associated with mitochondrial impairments. Indeed, we observed a significant reduction of the mitochondrial potential of neurons exposed to violet light in standard BP (Fig. 3k). This effect appeared to precede neuronal death (Supplementary Fig. 4c) and was comparable to exposing the neurons to 100 µM of H2O2. In contrast, the mitochondrial potential of neurons was not affected by light stimulation in BPI (Fig. 3k). Altogether, BPI was the only neuronal medium tested that showed no neuronal phototoxicity across the full visible light spectrum.
BPI supports optimal action potentials and synaptic activity in human neurons
We then asked whether BPI maintains the fundamental electrophysiological properties of human neurons. We used patch-clamping and MEA to test the effect of BPI on the electrophysiological activity of human neurons (Figs. 4 and 5). The neurons were matured from human PSC-derived neural progenitors in standard BrainPhys for 4–5 months before patch-clamping (Supplementary Fig. 6a). The cells were selected for patch-clamping based on their neuronal morphology visualized with synapsin:GFP lentiviral marker (Supplementary Fig. 6b). During the whole-cell recordings, we alternated the perfusion between BPI and artificial cerebrospinal fluid (ACSF), which is used as the gold-standard for acute electrophysiology. We first found that acute perfusion of BPI had no negative effect on the types of action potential (AP) firing patterns, which were defined previously in28 (AP Types 1–5; Supplementary Fig. 6c). To confirm that BPI does not have more subtle effects, we further examined the electrophysiological properties of “mature” neurons (Type 5). Our results show that the cellular mechanisms critical to generate action potentials were healthy in BPI, and we found no difference in the electrophysiology of the cells when patched in ACSF (Fig. 4 and Supplementary Fig. 6) or in standard BP (Supplementary Fig. 7). To measure evoked action potentials (in current-clamp) or voltage-gated sodium and potassium currents (in voltage-clamp), we maintained the resting potential at −70 mV (by injecting on average 50 pA of current) and applied incremental depolarizing steps of current/voltage (Fig. 4a and Supplementary Fig. 6d). Voltage-gated sodium/potassium currents, rheobase, AP amplitude, AP frequencies, and AP hyperpolarizing amplitudes were similar when the recording was made in BPI or in ACSF (Fig. 4c–i). When no current was injected in the patch-clamped neurons, their resting membrane potential was around −50 mV and their AP threshold approached physiological levels (−40mV) both in BPI and ACSF (Fig. 4c). No significant differences were found between the membrane resistance and capacitance of neurons patch-clamped in either BPI or ACSF (Fig. 4j, k). Our results demonstrate the capacity of human neurons to generate optimal action potentials in BPI.
Neural network communication is achieved via synaptic integration and a regulated balance of inhibition and excitation. In the human brain, the neurotransmitter glutamate is responsible for the majority of synaptic excitation, while GABA is responsible for the majority of synaptic inhibition. The summation of excitatory and inhibitory neurotransmitters governs the probability of postsynaptic action potential firing. Hence, we assessed whether BPI supports basic synaptic activity in human neurons. Voltage-clamp recordings from mature human neurons highlighted spontaneous synaptic events mediated by both AMPA and GABA receptors, when patched in BPI medium or ACSF (Fig. 4l). Voltage clamping at the reversal potential of anions (−70 mV) and cations (0 mV) was used to distinguish between glutamatergic (Na+ current-mediated) and GABAergic (Cl− current-mediated) events. We found no significant differences in any of the properties of AMPA-mediated synaptic events (amplitude, frequency, and kinetics) when mature human neurons were patch-clamped in BPI or in ACSF (Fig. 4m–p). The functional quality of the neuronal network can also be assessed by measuring the synchronicity of action potential firing on multielectrode arrays. We found similar synchronicity properties when comparing the activity of human neurons side-by-side either in BPI or BP with the same supplements (Fig. 5a–f). Altogether, our results demonstrate the capacity of human neurons to generate and integrate optimal synaptic communication in BPI.
The electrophysiology of the cells in standard BrainPhys or BPI media is equivalent to gold standard ACSF. However, maintaining neurons in ACSF for more than a few hours can induce signs of neurodegeneration. We also previously showed that ACSF is not adapted to culture neurons for extended periods of time even when adding supplements26. Here, we repeated these results by comparing the function of human cortical and midbrain neurons on MEA over 18 days either in standard BP basal, BPI basal, or ACSF (Fig. 5g, h). In these experiments, we added to all three basal media the same sets of supplements (N2-A, BDNF, GDNF, vitamin C, cAMP, laminin, and either SM1 for midbrain or IGF-1 and SM1 without vitamin A for cortical). The spontaneous electrical activity was similar at first, but after a few days, we observed a significant decline when cultured in ACSF. In contrast, over the same period, the firing activity of cortical and midbrain neurons remained strong in standard BrainPhys medium and BPI (Fig. 5g, h).
Functional live-cell imaging of human neuronal culture in BPI medium
Specific ions such as calcium (Ca2+) play essential roles in electrophysiological activity and vesicular release at synaptic terminals, and are commonly used as a proxy to measure electrophysiological activity with functional imaging. The level of Ca2+ in BP and BPI matches human brain physiological levels (1.1 mM CaCl2). We tested the potential of BPI to image the spontaneous calcium activity of live human neurons. We found that functional imaging can be performed in BPI with optimal performance equivalent to neurophysiological salt solution ACSF, and improved performance compared to NEUMO and FluoroBrite imaging media (Fig. 6). For signal quantification, we monitored changes in intracellular Ca2+ with a calcium-sensitive dye (Fluo-4 AM) while perfusing different media. Thousand two hundred and twenty-five regions of interest (ROIs) were selected at the soma of neurons across a total of thirteen field-of-views (FOVs) (Fig. 6a). The FOVs were imaged over 4 min at 5 Hz in each of the following perfusates: ACSF, BPI, FluoroBrite, and NEUMO media. To investigate the quality and kinetics of spontaneous calcium activity, we categorized the cells based on the type of detected events into (i) cells with calcium spikes (fast-rising phase events), (ii) cells with calcium waves (slow rising phases), (iii) cells with calcium waves & spikes (combined), or (iv) cells without any spontaneous activity (Supplementary Fig. 8a). BPI did not affect the frequency and amplitude of unitary events (fast-rising phase events, dF/F > 5%) in comparison to ACSF (Fig. 6b–d and Supplementary Fig. 8, Supplementary Movie 1). A similar proportion of fast-rising cell types was measured, when functional imaging was performed in ACSF compared to BPI (Fig. 6e, f and Supplementary Fig. 8). However, a significant decline in the number, proportion, and frequency of fast-rising cell types was observed, when the perfusates were switched to NEUMO or FluoroBrite media (Fig. 6i, j and Supplementary Fig. 9). For slow rising calcium events, no significant changes in kinetics and cell event types were identified when functional imaging was conducted in BPI compared to ACSF, NEUMO, or FluoroBrite (Fig. 6g, h, k, l and Supplementary Figs. 8, 9). The activity of the majority of these cell types was silenced with a voltage-gated sodium channel antagonist (tetrodotoxin, TTX; 1 µM), demonstrating that the calcium events observed are largely mediated by spontaneous action potential activity (Fig. 6e–g, i, k and Supplementary Figs. 8, 9b–e). We also alternated randomly the sequence of media tested to eliminate the possibility of order bias. Altogether, our results indicate that BPI provides optimal conditions for functional imaging of live human neurons in vitro.
BPI for optogenetics of human neurons
A panoply of optogenetic tools enables remote control of neuronal function with light2,7. To test that BPI is suitable for optogenetics experiments, we transfected human neurons in vitro with a lentiviral vector, to drive the expression of channel-rhodopsin tagged with a yellow fluorescent protein (ChETA-eYFP, which is based on ChR2 with two amino acid modifications to improve the kinetics and amplitude of light-evoked currents11). ChETA-eYFP was placed after a human synapsin promoter region (hSyn) to target the expression into neuronal cells. We patch-clamped human neurons expressing ChETA-eYFP (Fig. 7a). Flashes of blue light (5 ms, 100 ms intervals, at 475 nm) evoked action potentials in BPI comparable to ACSF in all neurons (Fig. 7b). Using the same light intensity and duration, we found that ten flashes of light at 10 Hz evoked action potentials at a success rate of 99–100% both in ACSF and BPI (Fig. 7c). The light-evoked conductance of ChETA was similar in BPI and ACSF (Fig. 7c). Interestingly, when human neurons expressing ChETA-eYFP were patch-clamped in NEUMO and stimulated using the same light parameters (5, 100 ms intervals, at 475 nm), a significant reduction in action potential success rates was witnessed (Fig. 7d and Supplementary Fig. 10). Furthermore, the action potential light-evoked success rate, peak amplitudes, and the conductance of ChETA remained significantly lower in NEUMO compared to BPI despite increasing LED power (at 475 nm) (Fig. 7e).
Our patch-clamping experiments were limited to acute changes of basal media. To test the longer-term effects of the media with supplements, we repeated these experiments with iPSC-derived neurons on a multielectrode array recorder (MEA). We first recorded the spontaneous electrical activity of neurons in alternative media for 1 week (three media changes). Overall, despite occasional variability in the level of spontaneous firing, we found no significant difference in the spontaneous activity of the neurons in standard BrainPhys or BPI (Fig. 7f). In contrast, when neurons were switched to NEUMO for a week, the spontaneous activity dropped and did not recover over time unless it was switched back to BrainPhys medium (Fig. 7f, g). The human neurons were also transfected with an optogene (LV hSyn:ChETA-EYFP) and stimulated with blue light (475 nm) while on the MEA recorder. Brief flashes of light were able to evoke action potentials in BPI but not in NEUMO (Fig. 7h, i). Altogether, this data demonstrates that BPI is optimal for optogenetic control of human neurons in vitro.
BPI supports the viability and function of neuronal cultures
Several components in the standard BrainPhys formulation were reduced or replaced to create BPI. Therefore, we wanted to determine whether the survival of neurons was compromised in BPI when culturing cells for extended periods of time. Both human and rat primary neurons cultured in BPI for 21 days exhibited healthy cell bodies and the expected neurite networks without apparent reduction in synaptic marker Synapsin1 (Fig. 8a). Importantly, the total number of live human or rat neurons in culture after 21 days in BPI was no different than in standard BrainPhys medium (Fig. 8b).
To determine if human neurons remain functional for extended periods in BPI, iPSC-derived neurons were tested on an MEA. After maturation for 6 weeks in standard BrainPhys medium, half the MEA plate was switched to BPI for a period of two weeks (Fig. 8c). Spontaneous mean firing rates and the proportion of active electrodes were similar between the wells kept in standard BrainPhys and those switched to BPI. Switching the cells back into the original BrainPhys after that period also did not affect the activity (Fig. 8c). Altogether, our data show that neuronal cultures are viable and functional when replacing standard BrainPhys for BPI with appropriate supplements for an extended period (2–3 weeks). For longer time periods, it is possible to alternate the feed with standard BrainPhys to replenish the light-sensitive nutrients reduced in BPI.
BPI basal medium was designed to enhance imaging capacity and support neuronal function in vitro. BPI proved advantageous for light-driven analysis of cultures of reprogrammed human brain cells and primary neurons. The most commonly used fluorophores in cell biology have a spectrum of excitation and emission from ultraviolet (~300 nm) to infrared. From ultraviolet to infrared, our data show that BPI optimizes the absorbance, autofluorescence, signal-to-background ratio, and phototoxicity, and outperforms other tissue culture media. Our data also shows that BPI supports physiological action potentials, synaptic activity, calcium spikes, and optogenetics function while supporting the long-term viability required for neuronal cultures.
We have shown that BPI can be used with multiple neuronal cell types in vitro, including human and rat, primary or reprogrammed, cortical or midbrain, 2D or 3D. Although we could not test all the possible experimental designs, we predict that most brain cell models in vitro or ex vivo should benefit from BPI in light-driven experiments. No experiment that we performed indicated that BPI might be limited to a particular neuronal cell type. Any cell type supported by standard BrainPhys will benefit from switching temporarily to BPI during light-driven experiments. Patient-derived iPSCs are increasingly popular for preclinical models of neurology28,29,30,31,32,33,34,35,36,37,38,39. BrainPhys medium and the imaging formula presented here were specifically designed with the intent to improve such human neuronal models.
We do not foresee any particular limitation in the type of live imaging experiment benefiting from BPI compared to the other neuronal media tested in vitro. The improvement in fluorescent signals and minimal photocytotoxicity in BPI can help most light-driven neuronal experiments, in particular, the ones with low signals and requiring higher light stimulation power18. In addition, the optimal support of electrophysiological activity is necessary for light-driven technologies used to monitor neuronal function (e.g., voltage-sensors, calcium-sensors, synaptic imaging, pH-sensors, and mitochondria motility)2,4,5,6,7,8,10. The discovery of personalized treatment with patient-derived neurons will benefit from drug screening in vitro40,41. Most drug screens use high-throughput microscopy to assess cell survival, which can be confounded by phototoxic media. Our data suggest that BPI will be the medium of choice for live-cell high-content imaging experiments in neurological and psychiatric research.
In the last decade, optogenetics has become a major research tool to interrogate the function of nerve cells in health and disease2,4,7,42,43. The integration of optogenetics with neural stem cells has enabled selective excitation and/or inhibition of specific cell populations expressing optogenes with exceptional precision, allowing researchers to investigate neural network function from innovative perspectives44,45,46,47,48. As BPI reduces photo-toxicity and optimizes electrical and synaptic activity, such conditions certainly improve optogenetics ability to assess neural networks. We have demonstrated that BPI is highly compatible with modulating the activity of human neurons in vitro with light excitation of ultrafast channel rhodopsin (ChETA). Similarly, BPI may also become advantageous for other optical experiments such as the photorelease of caged compounds13,14, or optical activation of intracellular antibodies15.
Standard BP with appropriate supplements and tissue culture techniques is capable of sustaining neuronal maturation for over 6 months in vitro26. In BPI, several components were reduced, removed or replaced from the standard BP to improve imaging capacity. We have shown that despite these modifications, BPI is capable of supporting cell viability and function (human neurons or rat primary neurons) for at least several weeks to similar levels observed in standard BrainPhys. However, BPI was designed to complement standard BrainPhys rather than replace it completely. It is hard to predict the viability effect of a medium on every cell type used in neuroscience research. It is possible that some cell types might be more sensitive than others. In some cases, it may be best to culture the cells in standard BrainPhys for the majority of the time and only switch to BPI when required for imaging assays. For longer-term imaging experiments of particularly sensitive cells, it is also possible to replenish the cells with standard BP every week or two. Despite this note of caution, based on our experiments, we are confident that using BPI for optical assays (short-term and long-term) will be better than using standard neuronal media. It is also important to note that like any other basal media, long-term viability requires the addition of appropriate supplements. In this study, we only tested the supplements generally recommended with standard BrainPhys (SM1 with or without Retinoic acid, N2-A, BDNF, GDNF, ascorbic acid, laminin, cAMP, and IGF-I), but it may be possible to obtain similar results with different sets of supplements if they are not phototoxic.
To surpass reported light-induced damage on cells cultured in Neurobasal or DMEM, two photostable basal media were developed: BrightCell™ NEUMO and FluoroBrite™ DMEM25. Our analysis confirmed some improvements in the autofluorescence of these media compared to standard media (Neurobasal, DMEM/F12, or standard BP). However, both media still exhibited mild autofluorescence and increased absorbance in shorter wavelength light, whereas the autofluorescence of BPI was significantly reduced throughout a wider light spectrum (300–800 nm). We do not know the cause of the residual fluorescence at shorter wavelengths in the other tissue culture media specialized for imaging, but it is likely that not all photoactive components were adjusted appropriately in these formulations. The optical superiority of BPI compared to other imaging media may be particularly prominent for experiments requiring peak excitation between 300 and 400 nm, such as blue fluorophores (e.g., DAPI, Hoechst, eBFP, Brilliant Ultraviolet, DyLight 405), calcium sensors (e.g., Fura-2), or other cellular sensors (e.g., Lysotracker Blue/MeOH). Compared to standard media such as BrainPhys, we observed significant increases in signal-to-background ratios in BPI with blue and green fluorophores. The prominence of the improvements may vary depending on the quality of the fluorophore and imaging system (e.g., lens magnification, numerical aperture values). No major differences were found in imaging red fluorophores in BPI and BP, which is likely attributed to the low absorbance and autofluorescence for long wavelengths (Fig. 1b, c). NEUMO was specifically designed for the culture of neuronal cells and to replace the Neurobasal medium during live-cell imaging25. However, when tested on human neurons in vitro, it failed to support spontaneous calcium spikes or optogenetic-induced action potentials. In general, the electrophysiological activity in NEUMO was substantially reduced compared to side-by-side recordings in ACSF or BrainPhys media. This result was consistent with multiple electrophysiological techniques including patch-clamping, calcium imaging, and MEA on human PSC-derived neurons. It also aligns with previous data obtained comparing the electrophysiological activity of human PSC neurons in standard BrainPhys and Neurobasal26. FluoroBrite DMEM is another photostable medium developed to replace DMEM in experiments requiring light stimulation. Like standard DMEM, FluoroBrite was not designed for neuronal cultures. Live calcium imaging data suggest that FluoroBrite is suboptimal for neuronal culture function. However, it is possible that it is better suited for other cell types. The suboptimal calcium spikes observed in NEUMO and FluoroBrite media may be related to their formulations driving higher calcium store release, and consequently suppressing neuronal activity by activating calcium-gated potassium currents and increasing action potential thresholds49. In a blind comparative analysis, our data show that BPI surpasses alternative photostable basal media when used on functional human PSC-derived neuronal culture.
Optically driven technology is known to induce phototoxic by-products in culture, leading to cellular death and metabolic alterations after light exposure. Furthermore, currently available imaging media, which were designed to limit phototoxicity, impair electrophysiological activity, and fail to support fundamental neurophysiological properties. The design of BPI is timely with the rapid expansion of functional imaging and human neuronal models in vitro. BPI, which is a reformulation of the standard BrainPhys basal medium, is found to improve optical properties throughout the entire light spectrum required for fluorophores and sensors used in cellular biology. The optically optimized properties of BPI will enhance the quality of results for a plethora of light-driven experiments in vitro. Such technical advancement provides a useful tool for preclinical models in vitro and may, in turn, facilitate translation in neurology and psychiatry.
All catalog numbers for reagents, antibodies, biological samples, and additional resources can be found in Supplementary Table 1 with corresponding source details.
Human pluripotent stem cell (hPSC)-derived neuron culture
Human neuron cultures were derived from pluripotent stem cells in two independent laboratories using slightly different protocols. Method #1 (Figs. 2–7 and Supplementary Figs. 2, 3, 6–10): WA09 (H9) ES cell colonies (Lot No. WB66595, WiCell) were maintained in mTeSR™1 (Cat. No. 85850, STEMCELL Technologies) as per manufacturer’s instructions on cell culture ware coated with hESC-qualified Matrigel (Cat. No. 356277, Corning). The cells were split by dispase treatment (Cat. No. 07923, STEMCELL Technologies) and mechanical scraping every 3–5 days onto fresh Matrigel. Embryoid body-based neural induction was performed based on a previous protocol26,50 with modifications. Briefly, hESCs were cultured in an ultralow attachment plate in a neural induction medium (NIM) consisting of DMEM/F12 with 15 mM HEPES (Cat. No. 36254, STEMCELL Technologies), 1× NeuroCult SM1 (Cat. No. 05711, STEMCELL Technologies), 1× N2 Supplement-A (N2-A; Cat. No. 07152, STEMCELL Technologies), 10 µM SB431542 (Cat. No. 72232, STEMCELL Technologies) and either 500 ng/ml Noggin (120-10C, PeproTech) or 100 nM LDN193189 (Cat. No. 72147, STEMCELL Technologies). Media was exchanged every other day for 7 days to allow embryoid bodies (EBs) formation. EBs were transferred to a tissue culture dish coated with 10 µg/ml poly-l-ornithine (Cat. No. P3655, Sigma) and 5 µg/ml laminin (Cat. No. 23017015, Thermo Fisher Scientific) in NIM supplemented with 1 µg/ml laminin. Media was exchanged every other day for 7 days until neural rosettes were clearly visible. Neural rosettes were manually selected under phase contrast (EVOS XL Core Imaging System, Thermo Fisher Scientific) and transferred onto fresh Matrigel-coated plates in neural progenitor medium (NPM). Midbrain neural progenitor differentiation: Midbrain neural progenitor medium (mNPM) was composed of DMEM/F12+ GlutaMAX (Cat. No. 10565018, Thermo Fisher Scientific) supplemented with 1× SM1, 1× N2-A, 200 ng/ml Sonic Hedgehog (Cat. No. 100-45, PeproTech), 100 ng/ml FGF8b (Cat. No. 100-25, PeproTech), 200 nM ascorbic acid (Cat. No. A4403, Sigma) and 1 µg/ml laminin. Cortical neural progenitor differentiation: Cortical neural progenitor medium (cNPM) consisted of DMEM/F12+ GlutaMAX plus 1× SM1, 1× N2-A, 10 ng/ml FGF2 (Cat. No. 78134, STEMCELL Technologies), 200 nM ascorbic acid and 1 µg/ml laminin. Neuronal progenitor cells (NPCs) were maintained at high density, fed every other day with fresh NPM and split about once a week at 1:3–1:4 ratio onto Matrigel-coated plates using Accutase (Cat. No. 07920, STEMCELL Technologies). For neuronal maturation, NPCs were dissociated and seeded at a density of 8 × 104 to 2 × 105 cells/cm2 (cell line dependent) onto tissue culture plates coated with 10 µg/ml poly-l-ornithine and 5 µg/ml laminin in neural maturation medium (NMM). Midbrain neuronal maturation medium (“mNMM”) was composed of BrainPhys™ (Cat. No. 05790, STEMCELL Technologies) supplemented with 1× SM1, 1× N2-A, 20 ng/ml BDNF (Cat. No. 78133.1, STEMCELL Technologies), 20 ng/ml GDNF (Cat. No. 78139.1, STEMCELL Technologies), 0.5 mM dibutyryl cyclic-AMP (Cat. No. D0627, Sigma), 200 nM ascorbic acid and 1 µg/ml laminin. Cortical neuronal maturation medium (“cNMM”) was composed of BrainPhys™ supplemented with 1× NeuroCult™ SM1 without vitamin A (Cat. No. 05731, STEMCELL Technologies), 1× N2-A, 20 ng/ml BDNF, 20 ng/ml GDNF, 10 ng/ml IGF-I (Cat. No. 78022.1, STEMCELL Technologies), 0.5 mM dibutyryl cyclic-AMP, 200 nM ascorbic acid and 1 µg/ml laminin. Half media changes with NMM were performed every 2–3 days. To improve neuronal culture quality and viability and achieve a more even distribution of cells for final neuronal maturation, postmitotic neuronal cultures 14 days postmaturation were routinely sorted (BD FACSMelody cell sorter, BD Biosciences) and live (DAPI negative) cells were replated at a density of 1.6–2.1 × 105 cells/cm2 (cell line dependent) on poly-l-ornithine-coated and laminin-coated glass coverslips or tissue culture-treated plates in NMM containing half concentration of growth factors.
Method #2 (Fig. 8a, b): frozen neural progenitor cells (NPCs) derived from embryonic (ES) or induced pluripotent stem (iPS) cells (XCL-1-derived neural stem cells, STiPS-M001 induced pluripotent stem cells, H14-derived neural stem cells and STiPS-B004 induced pluripotent stem cells51) were differentiated into neuronal precursors with the STEMdiff™ Neuron Differentiation Kit (Cat. No. 08500, STEMCELL Technologies). Neuronal precursor cells were then frozen with Cryostor CS10 (Cat. No. 07930; STEMCELL Technologies) in liquid nitrogen storage and thawed later for experiments. Post-thaw, cells were plated in 500 µl per well of STEMdiff™ Neuron Differentiation medium at 26,000–130,000 cells per cm2 (cell line dependent) in a 24-well plate. On day 1 post-thaw, 500 µl of BrainPhys™ (Cat. No. 05790, STEMCELL Technologies) or BrainPhys™ Imaging (Cat. No. 05796, STEMCELL Technologies) supplemented with 1× NeuroCult™ SM1, 1× N2-A, 20 ng/ml BDNF (Cat. No. 78005, STEMCELL Technologies), 20 ng/ml GDNF (Cat. No. 78058, STEMCELL Technologies), 200 nM ascorbic acid (Cat. No. 72132, STEMCELL Technologies), 1 μg/ml laminin (Cat. No. L2020, Sigma) and 0.5 mM dibutyryl cyclic-AMP (Cat. No. 73882, STEMCELL Technologies) [complete BrainPhys™] was added per well. Half media changes were performed every 3–4 days with complete BrainPhys™ or BrainPhys™ Imaging.
Neuronal Basal Media Tested
ACSF contained (in mM) 121 NaCl (Cat. No. S6191, Sigma), 4.2 KCl (Cat. No. 60128, Sigma), 1.1 CaCl2 (Cat. No. 21097, Sigma), 1 MgSO4 (Cat. No. 63138, Sigma), 29 NaHCO3 (Cat. No. S5761, Sigma), 0.45 NaH2PO4–H2O (Cat. No. S5011, Sigma), 0.5 Na2HPO4 (Cat. No. S5136, Sigma) and 20 glucose (Cat. No. G7021, Sigma). BrainPhys™ (Cat. No. 05790, STEMCELL Technologies), BrainPhys™ Imaging (Cat. No. 05796, STEMCELL Technologies), BrainPhys without Phenol Red (Cat. No. 05791, STEMCELL Technologies), FluoroBrite™ DMEM (Cat. No. A1896701, Thermo Fisher Scientific), DMEM/F12 (Cat. No. 10565018, Thermo Fisher Scientific), Neurobasal (Cat. No. 21103-049, Thermo Fisher Scientific), and BrightCell™ NEUMO (Cat. No. SCM146, Merck) were obtained via the source and catalog details provided. For long-term maturation of human neuronal culture, all basal media were supplemented with:
Human midbrain neurons supplements: 1× N2-Supplement A (Cat. No. 07152, STEMCELL Technologies), 1× NeuroCult™ SM1 (Cat. No. 05711, STEMCELL Technologies), 200 nM ascorbic acid (Cat. No. A4403, Sigma), 20 ng/ml or 10 ng/ml BDNF (Cat. No. 78133.1, STEMCELL Technologies), 20 ng/ml or 10 ng/ml GDNF (Cat. No. 78139.1, STEMCELL Technologies), 1 µg/ml laminin (Cat. No. 23017015, Thermo Fisher Scientific), and 0.5 or 0.25 mM dibutyryl cyclic-AMP (Cat. No. D0627, Sigma). Human cortical neurons supplements: 1× N2-Supplement A (Cat. No. 07152, STEMCELL Technologies), 1× NeuroCult™ SM1 without vitamin A (Cat. No. 05731, STEMCELL Technologies), 200 nM ascorbic acid (Cat. No. A4403, Sigma), 20 or 10 ng/ml BDNF (Cat. No. 78133.1, STEMCELL Technologies), 20 or 10 ng/ml GDNF (Cat. No. 78139.1, STEMCELL Technologies), 10 or 5 ng/ml IGF-I (Cat. No. 78022.1, STEMCELL Technologies), 1 µg/ml laminin (Cat. No. 23017015, Thermo Fisher Scientific), and 0.5 or 0.25 mM dibutyryl cyclic-AMP (Cat. No. D0627, Sigma). Two concentrations are listed for growth factors and dibutyryl cyclic AMP since these factors were reduced by 50% in the media after 2 weeks of neuronal maturation.
Generation of GFP-expressing human pluripotent stem cell line
WA01 (H1) embryonic stem cells (WiCell) were cultured in mTeSR™1 as per the manufacturer’s instructions (Cat. No. 85850, STEMCELL Technologies) plated on Matrigel™ (Cat. No. 356277, Corning). A stable GFP overexpressing cell line was generated by transfecting cells with a plasmid encoding GFP expression driven by the chicken beta-actin promoter52,53 using the Neon Transfection System (Thermo Fisher Scientific). H1 cells were dissociated to single cells and 1.2 × 106 cells were resuspended in 120 μl of R-buffer containing 2 μg of pCAG:GFP:IRES:Puro. Cells were then electroporated using the manufacturer’s instructions with the following settings: 1200 volts, 20 ms, 1 pulse. The transfected cell suspension was then added to 4 ml of mTeSR™1 supplemented with CloneR™ (Cat. No. 05888, STEMCELL Technologies), mixed by pipetting, then added to tissue culture-treated plates coated with Matrigel™ at 2.5 × 104 cells/cm2. The medium was replaced after 24 h and fed with fresh medium daily until the cells were ~60% confluent. The cells were then fed with fresh medium containing 1 μg/ml puromycin (Cat. No. 13844, Cayman Chemicals) daily to select for stable transfectants. Clonal cell lines were then generated by dissociating the H1-GFP cells to single cells and seeding at 10 cells/cm2 in mTeSR™1 supplemented with CloneR™ onto tissue culture-treated plates coated with Matrigel™. Cells were then fed 2 days post-plating with fresh medium supplemented with CloneR™, then fed daily following 4 days post-plating with mTeSR™1. Colonies were then picked manually between 7–9 days and cultured as outlined in “Human Pluripotent Stem Cell (hPSC)-derived Neuron Culture – Method #2”.
Generation of forebrain organoids
The dorsal forebrain organoids and ventral forebrain organoids were generated using the STEMdiff™ Dorsal Organoid Kit (Cat. No. 08620, STEMCELL Technologies) and STEMdiff™ Ventral Organoid Kit (Cat. No. 08630, STEMCELL Technologies) respectively54,55. Dorsal forebrain organoids were generated from unlabeled WA01 (H1) embryonic stem cells while the ventral forebrain organoids were generated from GFP-labeled WA01 (H1) embryonic stem cells. On day 0, hPSCs were washed with PBS and detached using Gentle Cell Dissociation Reagent (Cat. No. 07174, STEMCELL Technologies) for 8 min at 37 °C. Cells were resuspended in DMEM/F12 and centrifuged at 300×g for 5 min at room temperature. The supernatant was removed and hPSCs were then resuspended in Forebrain Organoid Formation Medium containing 10 μM Y-27632 (Cat. No. 10005583, Cayman Chemical) to a concentration of 3 × 106 cells/ml. An AggreWell™800 plate (Cat. No. 34811, STEMCELL Technologies) was prepared by pre-treating a well with 500 µl of Anti-Adherence Rinsing Solution (Cat. No. 07010, STEMCELL Technologies) followed by brief centrifugation at 2000×g for 5 min at room temperature, Anti-Adherence Rinsing Solution was removed by aspiration and replaced with 1 ml of Forebrain Organoid Formation Medium containing 10 μM Y-27632. To each AggreWell™800 well, 1 ml (3 × 106 cells) of cell suspension was added, and the plate was centrifuged at 100×g to capture cells into microwells. The plate was grown in an incubator at 37 °C and 5% CO2. From day 1–5, media was changed daily using partial medium changes (1.5 ml/well) using Forebrain Organoid Formation Medium. On day 6, neural aggregates were harvested using a wide-bore pipette tip to transfer aggregates onto a 37 µm reversible strainer (Cat. No. 27250, STEMCELL Technologies) to remove single cell debris. Organoids were added to a 6-well suspension culture plate (Cat. No. 27145, STEMCELL Technologies) with Forebrain Organoid Expansion Medium, approximately 25–50 forebrain organoids were distributed per well of the 6-well plate. For ventral forebrain organoids, STEMdiff™ Neural Organoid Supplement D (Cat. No. 08631, STEMCELL Technologies) was added to the Forebrain Organoid Expansion Medium. From day 6–24, full media exchange was performed every two days using Forebrain Organoid Expansion Medium for the dorsal forebrain organoids or Forebrain Organoid Expansion Medium containing STEMdiff™ Neural Organoid Supplement D for the ventral forebrain organoids. On day 25, the media was replaced with Forebrain Organoid Differentiation Medium for both the dorsal forebrain organoids and ventral forebrain organoids, with full media exchange performed every two days. At day 30, a single dorsal forebrain organoid and a single ventral forebrain organoid were removed from suspension culture using a wide-bore pipette tip and were placed together into one well of a 96‐Well U‐bottom plate (Cat. No. 7007, Corning) in 200 µl of Forebrain Organoid Differentiation Medium. The forebrain organoids were fed every two days using half-media exchange (100 µl per well) and were allowed to form an assembloid over one week.
Pairs of Rat E18 cortices (Cat. No. SDECX, BrainBits, LLC) were dissociated for 10 min in papain (Cat. No. LK003176; Worthington Biochemical; at least 20 U/ml). A single-cell suspension was obtained and filtered through a 40 μm cell strainer. The resulting primary cells were cultured in NeuroCult™ Neuronal Plating medium (Cat. No. 05713, STEMCELL Technologies) or Neurobasal medium for Neurobasal and NEUMO cultures (Cat. No. 21103-049, Thermo Fisher Scientific) with 1× SM1 (Cat. No. 05711, STEMCELL Technologies), 0.5 mM l-glutamine (Cat. No. 07100, STEMCELL Technologies) and 25 μM l-glutamic acid (Cat. No. G8415, Sigma) on culture-ware pre-coated with 10 µg/ml poly-D-lysine (Cat. No. P7280, Sigma). Cells were plated at 30,000 cells/cm2 in a 24-well plate. Five days post-plating, half media changes were performed every 3–4 days with either BrainPhys™ (Cat. No. 05790, STEMCELL Technologies), Neurobasal, BrightCell™ NEUMO (Cat. No. SCM146, Merck) BrainPhys™ without Phenol Red (Cat. No. 05791, STEMCELL Technologies), or BrainPhys™ Imaging (Cat. No. 05796, STEMCELL Technologies) supplemented with 1× SM1. Neurobasal and BrightCell™ NEUMO media were also supplemented with 0.5 mM l-glutamine.
To assess media osmolality, 20 μl of test media or supernatant collected from maturing human iPSC-derived cortical neurons before feeding was pipetted into a disposable tube (Cat. No. 22-046733, Advanced Instruments). A Fiske Micro-Osmometer, model 210 (Cat. No. 14-727-420, Advanced Instruments) was used and calibrated with 2000, 850, 290, and 50 mOsmol/kg standards. Before recordings, the calibration was referenced against 290 mOsmol/kg standards, and between recordings, the micro-osmometer probe was cleaned with a probe cleaner (Cat. No. 3MA800, Advanced Instruments). Three human cerebrospinal fluid (hCSF) samples were pooled from multiple subjects (1–4).
Absorption spectra of culture media
Absorption spectra were measured using a CARY 7000 spectrophotometer (Agilent Technologies) with an integrating sphere attachment and a cuvette center mount holder designed to measure the absorbance of liquid samples56. A 1 cm pathlength cuvette with all four clear sides was used with 3 ml of sample for each measurement and spectra were measured from 200 to 800 nm in 5 nm increments with a spectral bandwidth of 2 nm. Acquired spectra were baseline corrected and blank subtracted to obtain corrected absorption spectra.
Autofluorescence measurements of culture media
Media autofluorescence was tested in two independent laboratories using slightly different protocols and apparatus. Method #1 (Fig. 1c): Volumes (10 ml) of control and test media were aliquoted into a blacked-out 15 ml tube (Corning). A custom bifurcated fiber probe (200 μm, 0.22 NA) was dipped into the media. 375, 405, 488, and 532 nm excitation wavelengths (20 mW) were sequentially fired from a Toptica iCHROME MLE (Farmington). Emission spectra (400–700 nm) from each excitation wavelength were captured using a Horiba MicroHR (Kyoto, Japan) using a 500 ms integration time. The following long-pass filters were used for 375, 405, 488, and 532 nm generated spectra respectively: 405 nm (Cat No. LP02-405RU-25, Semrock Razoredge), 488 nm (Cat. No. LP02-488RE-25, Semrock Razoredge), 532 nm (Cat. No. LP03-532RE-25, Semrock Razoredge). Method #2 (Fig. 1d–f): Equal volumes (300 μl) of control and test media were pipetted into a CellCarrier-96 black plate with an optically clear bottom (Cat. No. 60055550, Perkin Elmer). A total of eight replicate wells per medium were tested with a BMG Labtech FLUOstar Omega using an excitation/emission of 355/460 (blue), 485/520 (green), 544/590 (red) and 584/620 nm (far-red). FLUOstar uses a high energy xenon flash lamp light source with a 100 Hz flash rate and 167 ms exposure time. The energy per flash emitted is 67 mJ and subjects each well to 1 mW of light power. Emission wavelengths were captured using a BMG Labtech photomultiplier tube detector (PMT) at a gain of 1000. Blue, green, red, and far-red filters utilized the respective bandwidths for their excitation/emission wavelengths: 20/20, 12/25, 20/20, and 10/20 nm. Acquired autofluorescence data was blank subtracted. For normalization, the mean fluorescence intensity in PBS was subtracted from the other media.
Lentiviral vectors were produced in Lenti-X™ 293T cells (Cat. No. 632180, Takara Bio) cultured in DMEM, high glucose, no glutamine (Cat. No. 11960044, Thermo Fisher Scientific) supplemented with 10% fetal bovine serum (Cat. No. 10-099-141, Thermo Fisher Scientific), 4 mM GlutaMAX supplement (Cat. No. 35050061, Thermo Fisher Scientific) and 1 mM sodium pyruvate (Cat. No. S8636, Sigma) on cell culture-ware coated with 0.002% poly-l-lysine (Cat. No. P7280, Sigma). Lenti-X™ 293T cells were transfected with 12.2 µg lentiviral transfer plasmid (LV Syn-hChR2-T159C-E123T-EYFP-WPRE [hSyn:ChETA-YFP11], or LV pCSC-Synapsin(0.5 kb)-MCS-EGFP, a derivative of pCSC-SP-PW-EGFP) and packaging plasmids (8.1 µg pMDL/RRE, 3.1 µg pRSV/REV, and 4.1 µg pCMV-VSVg) using a polyethylenimine (PEI, 25 kDa, linear; Cat. No. 23966-1, Polysciences) transfection method (4:1 ratio of PEI to DNA). The culture medium was exchanged six hours after transfection. The supernatant containing lentiviral particles was collected ~66 h after transfection, filtered through a sterile 0.45-µm SFCA membrane filter (Cat. No. 431200, Corning) and ultracentrifuged at 25,000 rpm at 4 °C for 2 h. Virus pellets were resuspended in Hank’s Balanced Salt Solution (Cat. No. 14025092, Thermo Fisher Scientific) and virus titers were determined using the Lenti-X™ qRT-PCR Titration Kit (Cat. No. 632180, Takara Bio) according to the manufacturer’s instructions. Neuron cultures were transduced with titer-matched lentiviral vectors (2.67 × 103 viral RNA copies/cell) for 48 h prior to wash. Lentiviral transfections in neuronal cultures were performed at least one week prior to experimentations. If expression levels were low, neurons were left in culture for an extra 3–5 days before further experimentations commenced.
Immunofluorescent staining protocol
Cultures were fixed in 4% paraformaldehyde (Cat. No. J61899, Alfa Aesar) at 22 °C for 30 min. Cells were then permeabilized with 0.1% Tween-20 (Cat. No. P7949, Sigma) in PBS (Cat. No. 37350. STEMCELL Technologies)) for 15 min. Cells were incubated overnight at 4 °C with anti-β-III-tubulin antibody (Cat. No. 801201, Lot No. B264428, Biolegend; 1:1000), anti-MAP2 antibody (Cat. No. ab5392, Lot No. GR3265288-3, Abcam; 1:5000) and/or anti-Synapsin I antibody (Cat. No. ab1543, Lot No. 2930537, Merck; 1:2000) diluted in PBS containing 10% normal donkey serum (Cat. No. S30, Merck). The next day cells were washed three times with PTW and incubated with antimouse Alexa Fluor®488 (Cat. No. 715-545-150, Lot No. 132977, Jackson Immunoresearch; 0.625 μg/ml), antirabbit Alexa Fluor®488 (Cat. No. 711-545-152, Lot No. 116141, Jackson Immunoresearch; 0.625 μg/ml), anti-chicken Alexa Fluor®488 (Cat. No. 703-545-155, Lot No. 116967, Jackson Immunoresearch; 0.625 μg/ml), antichicken Alexa Fluor®647 (Cat. No. 703-605-155, Lot No. 114163, Jackson Immunoresearch; 0.625 μg/ml) and/or antimouse DyLight®594 (Cat. No. 35510, Lot No. M163715, Thermo Fisher Scientific; 1 μg/ml) diluted in PBS containing 2% normal donkey serum overnight at 4 °C. Cells were then washed three times with PTW to remove residual antibodies. To detect the cell bodies, Hoechst 33342 (Cat. No. 14533, Lot No. 056M4091V, Sigma; 2 μg/ml) was used to counterstain the cells.
Neurofluor™ NeuO labeling protocol
E18 rat cortical neurons were cultured in BrainPhys™ (Cat. No. 05790, STEMCELL Technologies), BrainPhys™ Imaging (Cat. No. 05796, STEMCELL Technologies) or BrainPhys without Phenol Red (Cat. No. 05791, STEMCELL Technologies) for 11 days (16 days total) before labeling with NeuroFluor™ NeuO (Cat. No. 01801, STEMCELL Technologies). For labeling, the culture medium was aspirated and replaced with a labeling medium consisting of culture medium plus 0.25 μM NeuroFluor™ NeuO. Cells were incubated in the labeling medium for 1 h at 37 °C. After incubation, the labeling medium was replaced with fresh medium and cells were incubated at 37 °C for 2 h before imaging.
Either an SP8 confocal microscope (Leica), ImageXpress Micro 4 High Content Screening System (Molecular Devices) with an Andor SDK3 camera, CKX53 inverted microscope with an SC100 digital camera (Olympus), or a BX51 upright microscope (Olympus) with a PCO.Panda 4.2 digital camera were used for image acquisition. All images were taken using 16-bit cameras. Varying lens parameters and acquisition settings were used, as follows:
Fixed primary rat cortical neurons were acquired using an SP8 confocal microscope or an ImageXpress Micro 4 High Content Screening System. In Fig. 2e and Supplementary Fig. 1e, f, β-III-tubulin (TexasRed filter set: 562 ± 20/624 ± 20 nm, dichroic filter 593 nm) was imaged using the ImageXpress Micro 4 High Content Screening System at 500 ms with a 20× air immersion lens (Ph1 S Plan Fluor ELWD ADM; NA 0.45). For fluorophore excitation, the in-built Lumencor Sola Light (SE 5-LCR-QB) was set to 100 “lumencor intensity” units in MetaXpress (v6.2.2.) software. This same set-up was used in Supplementary Fig. 1c for Hoechst (DAPI filter set: 377 ± 25/447 ± 30 nm, dichroic filter 409 nm) with a 204 ms exposure time and Fig. 8b for β-III-tubulin (FITC filter set: 475 ± 17/536 ± 20 nm, dichroic filter 506 nm) and Hoechst (DAPI filter set) with 100 ms and 204 ms exposure times respectively. For Fig. 8a, b, Synapsin I, MAP2 and Hoescht were imaged using the SP8 confocal microscope with a 63× oil objective (HC PL APO CS2; NA 1.4) and the following settings: 405, 488, and 638 nm lasers with 26.7, 18.3, and 1 respective power intensities. The following detector settings for Synapsin I, MAP2 and Hoechst images were, respectively selected for: 410–483 nm (HyD) at gain 100, 493–643 nm (PMT) at gain 768.8, and 643–781 nm (HyD) at gain 40.3, Pinhole 1 AU, zoom 1×, and 400 Hz scan speed.
Imaging fixed hPSC-derived neurons (Fig. 8a, b)
Images of fixed hPSC-derived neurons were acquired using a Leica SP8 confocal microscope or ImageXpress Micro 4 High Content Screening System. MAP2 (Cy5 filter set: 628 ± 20/692 ± 20, dichroic filter: 660 nm) and Hoechst (DAPI filter set) from Fig. 7b were both imaged using the ImageXpress Micro 4 High Content Screening System with a respective 50 and 204 ms exposure time using a 20× air immersion lens (Ph1 S Plan Fluor ELWD ADM; NA 0.45). For all image acquisition using the ImageXpress, the in-built Lumencor Sola Light (SE 5-LCR-QB) was set to 100 “lumencor intensity” units in MetaXpress (v6.2.2.) software. In Fig. 7a, Synapsin I, MAP2 and Hoechst were imaged using a Leica SP8 confocal microscope with a 63× oil objective (HC PL APO CS2; NA 1.4) and the following settings: 405, 488, and 638 nm lasers at 1%, detectors 410–483 nm (HyD) at gain 142, 493–643 nm (PMT) at gain 768.8, and 643–781 nm (HyD) at gain 32.5, Pinhole 1 AU, Zoom 1×, Scan speed 400 Hz.
Live rat cortical neurons labeled with Neurofluor™ NeuO (FITC filter set: 475 ± 17/536 ± 20 nm, dichroic filter 506 nm) and Hoechst (DAPI filter set: 377 ± 25/447 ± 30 nm, dichroic filter 409 nm) were imaged using an ImageXpress Micro 4 High Content Screening System set at 25 and 204 ms exposure times respectively with a 20× air immersion lens (Ph1 S Plan Fluor ELWD ADM; NA 0.45). NeuroFluor™ NeuO has an excitation/emission spectrum of 470/555 nm. The in-built Lumencor Sola Light (SE 5-LCR-QB) was set to 100 “lumencor intensity” units in MetaXpress (v6.2.2) software for fluorophore excitation. Phase-contrast images (Fig. 3a–c and Supplementary Figs. 4b, 5, 7a) of live rat cortical neurons were taken with an Olympus CKX53 microscope with an SC100 digital camera and a 10× dry objective (CACHN10XIPC; NA 0.25).
Imaging live fused dorsal and ventral forebrain organoids (Fig. 2d)
Fused dorsal and ventral forebrain organoids were imaged using a Leica SP8 confocal microscope with 10× dry objective (HC PL APO CS2, NA 0.4) and the following settings: 488 nm laser at 5% power intensity, detector 493–547 nm (HyD) at gain 176.8, Pinhole 1 AU, Zoom 1×, Scan speed 600 Hz.
Fluorescent images of live hPSC-derived neurons transfected with green-fluorescent-protein (GFP) lentivector were imaged at 200 ms exposure time using a PCO.Panda 4.2 (16-bit) digital camera and Olympus BX51 upright microscope with 40× water immersion lens (LUMPLFLN40XW, 0.8NA, Semiapochromat). A cool-LED pE300 illumination unit was set to blue (460 nm) at 1% power (0.1 mW) and light passed through a single band FITC/Cy2 filter (Cat. No. 49002, Chroma) with a 470 nm excitation (±40 nm) and 525 nm emission (±50 nm) wavelength. Single neurons were perfused with BrainPhys™ (Cat. No. 05790, STEMCELL Technologies) basal media bubbled with a mixture of CO2 (5%) and O2 (95%) and maintained at room temperature. Perfusates were then switched to BrainPhys™ Imaging (Cat. No. 05796, STEMCELL Technologies) and then artificial cerebrospinal fluid (ACSF). Imaging parameters remained constant across all live neuron images in each perfusate. Phase-contrast images (Fig. 7a) of live hPSC-derived neurons were taken with an Olympus CKX53 microscope with an SC100 digital camera and a 10× dry objective (CACHN10XIPC, NA 0.25).
Quantification of cell viability with imaging for phototoxicity experiments
Live primary rat cortical neurons (Figs. 3d and 8b): neuron cultures for quantification were set up in triplicate wells and fixed for immunostaining with β-III-tubulin. Twenty-five images per well were taken using an ImageXpress Micro 4 High Content Screening System (Molecular Devices) for a total of 75 images per condition. Using a custom module designed for neuron quantification in MetaXpress 6.2.2 software (Molecular Devices), neurons in each image were counted based on the following parameters. Nuclei are masked if between 10.5 and 35 μm in width and 90 and 350 μm2 in area with an intensity above the local background of 500. Objects with a max intensity standard deviation above 2000 were excluded (excludes apoptotic nuclei). Masked area is then queried for presence of β-III-tubulin positive staining with an average intensity above 400. Images, where the neuron count was above 55, were excluded due to increased error in the presence of high nuclei counts. The average number of neurons per cm2 was calculated based on the image size (0.00508 cm2) produced from the 20× objective. Fixed hPSC-derived Neurons (Fig. 8b): Neurons for quantification were set up in duplicate wells and fixed for immunostaining on days 14–21. Sixteen images were taken per well and quantified as described above based on the presence of MAP2 positive staining. The average number of neurons per cm2 was calculated as described above.
Fluorescent signal-to-background ratios
iPSC-derived human neurons (Fig. 2b, c): the mean “signal” intensity of human neurons expressing synapsin:GFP were analyzed per field-of-view (FOV) by computing the mean gray values of ROI manually selected around soma and/or neurites with ImageJ’s “multimeasure” function57. Whether the signal intensity at soma and neurites were analyzed together or individually is detailed in figure legends. To analyze the mean ‘background’ intensity in each test media, ROIs were traced around regions without neurons (i.e., cellular bodies or neurite projections) and the mean gray values generated. Signal-to-background ratios were calculated using the following formula: ((signal intensity—background intensity)/background intensity). Per FOV, “signal” and “background” analyses were repeated using the same ROIs across test conditions. Primary rat cortical neurons (Fig. 2f and Supplementary Fig. 1c–e): mean “signal” intensity analysis on the fluorescence staining of fixed and live primary rat cortical neurons was conducted per FOV using ImageJ’s57 “3D object counter” (Fig. 2f) or “Triangle” auto-threshold (Supplementary Fig. 1c–e) in mean gray value units. In Fig. 2f, the fluorescence “signal” from Hoechst, NeuO and β-III-tubulin above 3600, 600, and 7000 (mean gray value units) were masked, respectively. Mean “signal” intensity values of masked regions greater than 30 pixels in size (pixels2) were computed with “3D object counter”. In Supplementary Fig. 1c–e, ROIs of Hoechst, NeuO and β-III-tubulin fluorescence stains were generated from binary masks obtained from autoselection/thresholding. ROI outlines were overlapped onto the corresponding original image(s). ImageJ’s “multi-measure” function was used to calculate the mean “signal” intensity of masked regions greater than 30 pixels in size (pixels2). For mean “background” intensity analysis, “background” ROIs (i.e., with no cellular bodies or neurite projections) were generated per FOV from binary masks obtained using ImageJ’s “Huang dark” threshold (Fig. 2f) or “Triangle dark” auto-threshold (Supplementary Fig. 1c–e). “Background” ROIs were overlapped onto the corresponding original image(s) and the mean gray value units computed per FOV using ImageJ’s “multimeasure” function57. Threshold settings remained constant for each fluorescent stain to maintain consistency between replicates. Objects on edges were excluded from all mean intensity results. Signal-to-background ratios were calculated using the following formula: ((signal intensity – background intensity)/background intensity).
GFP intensity values were computed per pixel from ROIs selected at “background”, “neurites”, and “soma” regions, as described under “Fluorescent Signal-to-Background Ratios” for iPSC-derived neurons. Using Image J’s “Histogram” command57, ROIs were analyzed using 1240 bins in the intensity range from 60 to 1300. Mean GFP intensity results across all FOVs were graphed either against the cumulative percentage of pixels (Fig. 2b) or the number of pixels (Supplementary Fig. 2b). All data were paired across test conditions. The number of photo-counts of the camera sensor without cells and media were included and labeled as “dark” (Fig. 2b and Supplementary Fig. 2b).
LED exposure for phototoxicity experiments (Fig. 3a–d and Supplementary Fig. 5)
A string of battery-operated blue (Cat. No. ED0193L, ER CHEN), red (Cat. No. ED00021, ER CHEN) and violet (Cat. No. UV443528WP, AMARS) LED lights were wrapped around a tissue culture plate. The plate containing the lights was then placed above the test culture plate (containing cultures of primary E18 rat cortical neurons) in a temperature-controlled incubator. The test plate was exposed to light for 12 h total (two bouts of 6 h, 24 h apart) for blue LEDs (450–475 nm; 14 Lux ± 1.41 S.E.M), 18 h for red LEDs (620–740 nm; 55 Lux ± 4.99 S.E.M) and 6 h for violet LEDs (395–405 nm; 430 Lux ± 3.70 S.E.M). Light meter readings were taken of the plate containing the LEDs at eight points over the plate area with a Sper Scientific™ model 840020 light meter (Cat. No. 840020, Sper Scientific).
Primary rat cortical neurons were cultured in 96 well plates precoated with 30 µg/ml poly-d-lysine (Cat. No. P7280, Sigma) at 23,400 cells/cm2. On day 13 or 14, cultures were exposed to violet LED light for 1 h in a humidified incubator at 37 °C with 5% CO2 and 21% O2 with a rest period of 2–3 h post-exposure before fluorescent assays. For H2O2 exposure, 3% (0.88 M) hydrogen peroxide solution (Cat. No. 88597, Sigma) was diluted to 100 μM final concentration in culture wells and cells were incubated for 4 hours in a humidified incubator at 37 °C with 5% CO2 and 21% O2. For fluorescent assays, the culture medium was removed from all wells and replaced with 200 µl BPI. Twenty microliter of CellTiter-Blue® Reagent (Cat. No. G8081, Promega) was added per well in triplicate wells for each medium condition. After incubation in 37 °C with 5% CO2 and 21% O2 for 30 min, a JC-1 probe reconstituted in dimethyl sulfoxide (Cat. No. T3168, Thermo Fisher Scientific) was added to the second set of triplicate wells to 2 µg/ml final concentration. Plates were then incubated for another 30 min at 37 °C with 5% CO2 and 21% O2. Wells containing JC-1 probe were subsequently washed by performing two half-medium changes with BPI. Fluorescence was read using a SpectraMax M5 Multimode Microplate Reader (Molecular Devices) at wavelengths: 485 nm Ex/535 nm Em (JC-1 monomers), 535 nm Ex/595 nm Em (JC-1 aggregates), and 560 nm Ex/590 nm Em (CellTiter-Blue® cell viability). Fluorescence readings were taken in triplicate for each well in a horizontal scan pattern. Blank values were subtracted from all readings in SoftMax Pro software (version 7.1). Values were averaged across triplicate readings and wells for each condition. Ratio of JC-1 aggregates to monomers was calculated by dividing the value of 595 nm emission by the value of 535 nm emission.
Media cytotoxicity comparisons (Fig. 3e, f)
LDH assay for cell viability: LDH release in human neuronal cultures treated with light-stimulated neuronal maturation media was measured to assess loss of cell viability. Media was made and stimulated with ambient tissue culture hood light for 24 h as described under “H2O2 measurements”. Human midbrain and cortical neurons were matured and treated in 48-well (Fig. 3g) and 96-well (Fig. 3h) culture plates, respectively. Treatment: neuronal maturation media was replaced with 24-h light stimulated media (Day 0). Half-Media changes were performed every 24 h (Day 1, Day 2…) using fresh 24-h light stimulated media. Supernatant samples were collected on Day 0 immediately after feeding, and immediately before feeding on Day 1 onwards for the LDH assay. Samples were frozen at −20 °C prior to LDH measurement. LDH assay: LDH was measured using CytoTox 96® nonradioactive cytotoxicity assay (Cat. No. G1780, Promega) as per the manufacturer’s protocol. Formazan absorbance at 490 nm was measured by GloMax microplate reader (Promega) using GloMax (v3.1) software. Blank LDH levels were subtracted from Treatment LDH values. Normalization can be found in figure legends. For Fig. 3e, f, luminescence measurements were normalized first to BPI results for each respective day, then values were renormalized to day 0.
H2O2 measurements in light stimulated media (Fig. 3g, j)
Media: BrainPhys and BPI basal media were supplemented to make neuronal maturation media as described under “Human Pluripotent Stem Cell (hPSC)-derived Neuron Culture” (Method #1). Media was made fresh for each experiment and stimulated with blue or ambient light for 24 h. Lumos optical stimulation (at 475 nm): 500 µl of media was added to the wells of a 48-well Lumos MEA plate (Cat. No. M768-tMEA-48OPT, Axion Biosystems). The 48-well Lumos MEA plate was maintained at 37 °C, 5% CO2 environment within a Maestro Pro MEA system (Axion Biosystems). The media were stimulated with blue light (475 nm) for 24 h using a Lumos optical stimulator (Axion Biosystems) adapted for 48-well MEA plates. Stimulation was repeated with the following settings: 10 × 5 ms flashes of blue LED light at 10 Hz and a 30-s interburst interval. Incremental blue LED power intensities were used (0, 3, 5, 12, 27, 53, 79, and 105 mW). The light intensity (mW) of blue light emitted from a Lumos optical stimulator (Axion Biosystems) was measured using a PM100D Compact Power and Energy Meter Console (Thor Labs) set to 475 nm (Supplementary Fig. 4a). Ambient light stimulation: 500 μl of media was added to the wells of a 48-well plate (Corning CoStar). Forty-eight-well plates were placed in a Cellgard ES ClassII biological safety cabinet (Cat. No. S480-600E, Nuaire) and stimulated for 24 h with a 58-watt NL-T8 Fluorescent Lamp Spectralux©Plus (Radium) located at the ceiling of the cabinet. The lamp is 1.5 m in length with a 2.5 mg mercury content and medium bi-pin G13 bas, giving rise to a 5200 lm luminous flux. Control plates were wrapped with aluminum foil to protect them from light. H2O2 Luminescence Measurements: H2O2 measurements were made using ROS-Glo™ (Cat. No. G8820, Promega) kits as per the manufacturer’s protocol. Upon concluding light stimulation, H2O2 substrate was added to sample media to a final concentration of 25 µM. Samples were incubated for 2 h in a dark humidified incubator at 37 °C with 5% CO2 and 21% O2. Samples were transferred to an opaque black-walled 96-well plate in triplicates, combined with an equal volume of ROS-Glo™ Detection solution, and incubated for 20 min before relative luminescence units (RLU) was measured on a GloMax microplate reader (Promega) using GloMax (v3.1) software.
Light spectra recordings
Ambient light (Fig. 3h): to assess emission spectra from a 58-watt NL-T8 Fluorescent Lamp Spectralux©Plus (Radium) in a Cellgard ES ClassII biological safety cabinet (Cat. No. S480-600E, Nuaire), a Flame VIS-NIR spectrometer (Ocean Insight) with a 10 μm slit was placed in the cabinet, facing the white-light fluorescent lamp. The emission spectra were captured using an integration time of 2 ms. LUMOS optical stimulator at 475 nm (Fig. 3i): To assess emission spectra from the Lumos optical stimulator (Axion Biosystems) set to a wavelength of 475 nm, a Flame VIS-NIR spectrometer (Ocean Insight) installed with a 10 μm slit was placed approximately 1 cm away from a single LED on the Lumos optical stimulator. The emission spectra were captured using an integration time of 1 ms.
hPSC-derived neurons attached onto coverslips in 48-well plates were incubated with a 0.5 μl of Fluo4-AM(1 mM; Cat. No. F14201, Thermo Fisher Scientific) in 500 μl of neuromedium, per well (final Fluo-4 AM concentration in media: 1 μM). Incubation occurred for 20 min in a humidified incubator at 37 °C with 5% CO2 and 21% O2. Excess dye was removed by washing three times with ACSF. The cells were then transferred into a room-temperature recording chamber continuously perfused with ACSF and bubbled with a mixture of CO2 (5%) and O2 (95%) for an additional 30 min at room temperature to allow de-esterification. Fluo-4 AM concentrations lower than 2 μM and loading times less than 30 min did not induce harmful effects to the neurons58. Time-lapse image sequences were acquired at 5 Hz over 4 min with a region of 248 × 248 pixels. Images were recorded at 200 ms exposure time using a PCO.Panda 4.2 digital camera and an Olympus BX51 upright microscope with a 10× water immersion lens (UMPLFN10XW, NA0.3, Semi-Plan Apochromat) and FITC/Cy2 filter set (Cat. No. 49002, Chroma). A cool-LED pE300 illumination unit was set to 460 nm (1%; 0.1 mW) to exciteFluo4-AM. Imaging parameters were kept constant when recording in different test media. To assess network activity in response to different media, the following were perfused into the bath over 6 min at a constant rate of 0.32 ml/min: ACSF, BPI, BP, NEUMO, FluoroBrite. At the end of the experiment before discarding the culture 1 µM Tetrodotoxin (TTX; Cat. No. ab120054, Abcam) perfusate was added to the basal media to block voltage-gated sodium channels and action potential generation. The orders of media perfusion were alternated, apart for TTX, which was always perfused last. Images were then processed using ImageJ software. A heat-map LUT was applied to each image sequence to visualize calcium events as changes in fluorescence over baseline. A ROI was placed around each soma displaying a defined cellular morphology and at least one clear neuronal calcium event (dF/F > 5%, fast rise, slower decay). A time series for each ROI was calculated using ImageJ57 and Microsoft Excel before analysis in Clampfit (v10.7). Different types of calcium events were manually categorized as either calcium waves, spikes or a combination of calcium waves and spikes (Supplementary Fig. 8a).
Individual coverslips containing neurons were transferred into a recording chamber at room temperature (21 °C) continually perfused at 0.32 ml/min with either ACSF or BrainPhys™ Imaging media bubbled with a mixture of CO2 (5%) and O2 (95%). Whole patch recordings were made on neurons expressing the previously infected synapsin:GFP lentiviral vector. Targeting whole-cell recordings were achieved via a 40× water-immersion objective, and a PCO.Panda 4.2 digital camera on an Olympus BX51 microscope. A cool-LED pE300 illumination unit at 460 nm was used to visualize neurons expressing synapsin:GFP. Patch electrodes were filled with internal solutions containing 130 mM K‐gluconate, 6 mM KCl, 4 mM NaCl, 10 mM Na-HEPES, 0.2 mM K‐EGTA, 0.3 mM GTP, 2 mM Mg-ATP, 0.2 mM cAMP, 10 mM d‐glucose, 0.15% biocytin and 0.06% rhodamine for somatic (open tip resistance 3–5 MΩ) whole-cell recordings. The pH and osmolarity of the internal solution were close to physiological conditions (pH 7.3, 290–300 mOsmol). AMPA-receptor mediated events were observed exclusively in voltage-clamp at −70 mV (close to anion reversal potential). GABAa-receptor-mediated kinetics were observed exclusively in voltage-clamp at 0 mV (close to cation reversal potential). Recorded membrane potential values were adjusted for pipette offset. Electrode capacitance was compensated for in cell-attached mode. Signals were low-pass filtered (DC to 20 kHz) and acquired by PClamp software. Whole-cell recordings were amplified via a Digidata 1440A/Multiclamp series 700B. On average the neurons recorded had an access resistance of ~22 ± 7 MΩ (Mean ± Stdev). The average patch-pipette resistance used was 3.8 ± 0.5 (Mean ± Stdev). Final data were analyzed using a combination of Clampfit (v10.7) and GraphPad Prism 8 and were corrected for liquid junction potentials (10 mV).
Action potential (AP) type classification
AP type classification was based on previously published definition (Bardy et al.28) as follows: “Type 0 cells” are most likely non-neuronal and do not express voltage-dependent sodium currents. “Type 1 neurons” express small Nav currents but are not able to fire APs above −10 mV. The limit of −10 mV was chosen as it is close to the reversal potential of cations (0 mV), and a sign of healthy mature APs. “Type 2 neurons” fire only one AP above −10 mV, which is typically followed by a plateau. “Type 3 neurons” also fire an AP above −10 mV and one or a few aborted spikes below −10 mV. “Type 4 neurons” fire more than one AP above −10 mV but at a frequency below 10 Hz. “Type 5 neurons” fire APs above −10 mV at 10 Hz or more.
Optogenetics during patch-clamping
Blue light stimuli (475 nm) were controlled by a computer-controlled trigger signal to the LED illuminator (pE300; CoolLED) synchronized with the pClamp protocols through a Master 9 programmable pulse stimulator (A.M.P.I.). The patched neurons were stimulated with a burst consisting of ten flashes of blue (475 nm) light of a duration of 5 ms at 10 Hz. Each burst stimulus was repeated at least ten times every 10 s for each cell. The intensity of the blue light at 475 nm tested here ranged between 0.1, 0.2, and 0.4 mW. Illumination was achieved via an Olympus BX51 upright microscope, through a 40× water immersion lens (LUMPLFLN40XW, 0.8NA, Semiapochromat) focused on the soma and surrounding of the patch-clamped neurons.
Multielectrode arrays (MEAs)
MEAs recordings were performed in two independent laboratories with slightly different equipment and protocols. The two methods differed as follow:
Cell culture on MEA plates #1: The neuronal cultures were generated from NPCs in the neural maturation medium (NMM) as outlined under hPSC-derived neuron culture. Fourteen days after neuronal maturation in NMM, cultures were dissociated using Accutase (Cat. No. 07920, STEMCELL Technologies) and resuspended in NMM at 15,000 viable neurons/µl. A 10 µl droplet of cell suspension was added directly over the recording electrodes of each well of the MEA, which were previously coated with 10 µg/ml poly-l-ornithine (Cat. No. P3655, Sigma) and 5 µg/ml laminin (Cat. No. 23017015, Thermo Fisher Scientific). Sterile water was added to the area surrounding the wells, and the MEA was incubated at 37 °C, 5% CO2 in a cell culture incubator. After 1 h, 300 µl NMM was gently added to each well. Half of the culture medium was exchanged with fresh medium three times per week. Fifty-two days after maturation commenced, the medium was replaced with one of three different media: BrainPhys™ Imaging, artificial cerebrospinal fluid (ACSF) or BrainPhys™, each supplemented with the midbrain or cortical basal media supplements. MEA recording and analysis #1: MEA recordings were taken by a Maestro Pro MEA system (Axion Biosystems). Lumos MEA 48 plates (Cat. No. M768-tMEA-48OPT, Axion Biosystems) were maintained at 37 °C with 5% CO2 environment during recordings. Recordings were not made for at least 10 min after transferring a plate into the MEA. Version 2.4 AxIS acquisition software (Axion Biosystems) was used to sample voltage potentials simultaneously across 16 electrodes per well. The sampling frequency was 12.5 kHz. The threshold for detecting spikes was set on a per-electrode basis and was defined as the voltage exceeding six standard deviations away from the mean background noise..spk files were analyzed using NeuralMetricTool version 2.5.1 software (Axion Biosystems). An electrode was defined as active with a mean firing rate greater than 0.017 Hz (>1 spike per min). Optogenetics on MEA #1: Optical stimulation parameters were configured using Stimulation Studio software in AxIS. Optical stimulation was performed by a Lumos optical stimulator (Axion Biosystems). The Lumos stimulation protocol was as follows: Every 20 s, wells were simultaneously exposed to a stimulation burst consisting of ten flashes of blue (475 nm) light, each lasting 10 ms with a 100 ms interval between each flash. Lumos blue LED stimulation at 100% intensity is >3.9 mW/mm2 according to the manufacturers. The intensities of stimulation used here ranged from 5 to 50%. Spontaneous and light-evoked firing rates were recorded for 10 min postfeeding neuronal cultures.
MEA method #2 (Fig. 8c)
Cell culture on MEA plates #2: Frozen neural progenitor cells (NPCs) induced pluripotent (iPS) stem cells (characterized in the ref. 51) were differentiated into neuronal precursors with the STEMdiff™ Neuron Differentiation Kit (Cat. No. 08500, STEMCELL Technologies). Neuronal precursor cells were then frozen with Cryostor10 (Cat. No. 07930, STEMCELL Technologies) in liquid nitrogen storage and thawed later for experiments. Post-thaw, cells were plated at 10,000 cells in a 40 µl droplet of STEMdiff™ Neuron Differentiation medium in a Cytoview MEA 48 plate (Cat. No. M768-tMEA-48B Axion Biosystems) pre-coated with 15 μg/ml poly-l-ornithine (Cat. No. P4957, Sigma) and 10 μg/ml laminin (Cat. No. L2020, Sigma) (12-wells total). After a 2-h incubation in a temperature-controlled incubator, 150 µl of the medium was added to each well. On post-thaw day 1, 150 µl of complete BP was added to each well. One well of the total 12 was eliminated from testing due to poor cell adhesion. Cells were cultured for 6 weeks in complete BP with half-media changes performed every 3–4 days. Subsequently, media in 5 out of 11 of the wells was exchanged with complete BPI for a period of 2 weeks before switching back to BP. MEA recording and analysis #2: Spontaneous neuronal activity was acquired at 37 °C under a 5% CO2 atmosphere using a Maestro system (Axion Biosystems) at a sampling rate of 12.5 kHz/channel. For recording, a Butterworth band-pass filter (200–3000 Hz) was applied and the adaptive threshold spike detector was set at 6× standard deviation. A 15-min recording was taken twice a week. Data from the last 10 min of each recording was exported for analysis using AxIS software v2.5.1 (Axion Biosystems). An electrode was defined as active with a mean firing rate greater than 0.017 Hz.
Statistical analyses were performed with Graphpad Prism 8. Significance was assessed between different media and BrainPhys™ Imaging groups using the following statistical tests: two-tailed nonparametric unpaired (Mann–Whitney) test, two-tailed unpaired t-test; two-tailed nonparametric paired (Wilcoxon) test; and one-sided sum-of-squares F-test.
Experimental procedures with human cells were performed in accordance with The Women’s and Children’s Health Network Human Research Ethics Committee in South Australia (HREC/17/WCHN/70). Human cells were collected from patients with informed consent. H1 (WA01) or H9 (WA09) human embryonic stem cells were obtained from WiCell (Agreement No. 20-W0500). Ethics approvals for tissue collection and sale are retained by the vendor. Rodent tissue was purchased from a commercial supplier (Brain Bits, LLC) whose procedures are approved by an Institutional Animal Use and Care Committee.
Further information on research design is available in the Nature Research Reporting Summary linked to this article.
The data that support the findings of this study are available from the corresponding author upon reasonable request.
Tsien, R. Y. The green fluorescent protein. Annu. Rev. Biochem. 67, 509–544 (1998).
Scanziani, M. & Hausser, M. Electrophysiology in the age of light. Nature 461, 930–939 (2009).
Boyden, E. S., Zhang, F., Bamberg, E., Nagel, G. & Deisseroth, K. Millisecond-timescale, genetically targeted optical control of neural activity. Nat. Neurosci. 8, 1263–1268 (2005).
Zhang, F., Aravanis, A., Adamantidis, A. R., de Lecea, L. & Deisseroth, K. Circuit-breakers: optical technologies for probing neural signals and systems. Nat. Rev. Neurosci. 8, 577–581 (2007).
Häusser, M. & Smith, S. Neuroscience: controlling neural circuits with light. Nature 446, 617–619 (2007).
Hochbaum, D. R. et al. All-optical electrophysiology in mammalian neurons using engineered microbial rhodopsins. Nat. Methods 11, 825–833 (2014).
Miesenbock, G. The optogenetic catechism. Science 326, 395–399 (2009).
Grienberger, C. & Konnerth, A. Imaging calcium in neurons. Neuron 73, 862–885 (2012).
Kiskinis, E. et al. All-optical electrophysiology for high-throughput functional characterization of a human iPSC-derived motor neuron model of ALS. Stem Cell Rep. 10, 1991–2004 (2018).
Abdelfattah, A. S. et al. Bright and photostable chemigenetic indicators for extended in vivo voltage imaging. Science 365, 699–704 (2019).
Gunaydin, L. A. et al. Ultrafast optogenetic control. Nat. Neurosci. 13, 387–392 (2010).
Zhang, F. et al. Optogenetic interrogation of neural circuits: technology for probing mammalian brain structures. Nat. Protoc. 5, 439–456 (2010).
Lutz, C. et al. Holographic photolysis of caged neurotransmitters. Nat. Methods 5, 821–827 (2008).
Ellis-Davies, G. C. Caged compounds: photorelease technology for control of cellular chemistry and physiology. Nat. Methods 4, 619–628 (2007).
Yu, D. et al. Optogenetic activation of intracellular antibodies for direct modulation of endogenous proteins. Nat. Methods 16, 1095–1100 (2019).
Laissue, P. P., Alghamdi, R. A., Tomancak, P., Reynaud, E. G. & Shroff, H. Assessing phototoxicity in live fluorescence imaging. Nat. Methods 14, 657–661 (2017).
Wang, R. J. Effect of room fluorescent light on the deterioration of tissue culture medium. Vitro 12, 19–22 (1976).
Bogdanov, A. M. et al. Cell culture medium affects GFP photostability: a solution. Nat. Methods 6, 859–860 (2009).
Waldchen, S., Lehmann, J., Klein, T., van de Linde, S. & Sauer, M. Light-induced cell damage in live-cell super-resolution microscopy. Sci. Rep. 5, 15348 (2015).
Icha, J., Weber, M., Waters, J. C. & Norden, C. Phototoxicity in live fluorescence microscopy, and how to avoid it. Bioessays 39, 1700003 (2017).
Grzelak, A., Rychlik, B. & Bartosz, G. Light-dependent generation of reactive oxygen species in cell culture media. Free Radic. Biol. Med. 30, 1418–1425 (2001).
Hockberger, P. E. et al. Activation of flavin-containing oxidases underlies light-induced production of H2O2 in mammalian cells. Proc. Natl Acad. Sci. USA 96, 6255–6260 (1999).
Roberts, J. E., Wielgus, A. R., Boyes, W. K., Andley, U. & Chignell, C. F. Phototoxicity and cytotoxicity of fullerol in human lens epithelial cells. Toxicol. Appl. Pharm. 228, 49–58 (2008).
Zigler, J. S. Jr, Lepe-Zuniga, J. L., Vistica, B. & Gery, I. Analysis of the cytotoxic effects of light-exposed HEPES-containing culture medium. In Vitro Cell Dev. Biol. 21, 282–287 (1985).
Stockley, J. H. et al. Surpassing light-induced cell damage in vitro with novel cell culture media. Sci. Rep. 7, 849 (2017).
Bardy, C. et al. Neuronal medium that supports basic synaptic functions and activity of human neurons in vitro. Proc. Natl Acad. Sci. USA 112, E2725–E2734 (2015).
Pasca, S. P. Assembling human brain organoids. Science 363, 126–127 (2019).
Bardy, C. et al. Predicting the functional states of human iPSC-derived neurons with single-cell RNA-seq and electrophysiology. Mol. Psychiatry 21, 1573–1588 (2016).
Mattis, V. B. & Svendsen, C. N. Induced pluripotent stem cells: a new revolution for clinical neurology? Lancet Neurol. 10, 383–394 (2011).
Bellin, M., Marchetto, M. C., Gage, F. H. & Mummery, C. L. Induced pluripotent stem cells: the new patient? Nat. Rev. Mol. Cell Biol. 13, 713–726 (2012).
Shi, Y., Inoue, H., Wu, J. C. & Yamanaka, S. Induced pluripotent stem cell technology: a decade of progress. Nat. Rev. Drug Discov. 16, 115–130 (2017).
van den Hurk, M. & Bardy, C. Single-cell multimodal transcriptomics to study neuronal diversity in human stem cell-derived brain tissue and organoid models. J. Neurosci. Methods 325, 108350 (2019).
Sarkar, A. et al. Efficient generation of CA3 neurons from human pluripotent stem cells enables modeling of hippocampal connectivity in vitro. Cell Stem Cell 22, 684–697 e689 (2018).
Chailangkarn, T. et al. A human neurodevelopmental model for Williams syndrome. Nature 536, 338–343 (2016).
Mertens, J., Marchetto, M. C., Bardy, C. & Gage, F. H. Evaluating cell reprogramming, differentiation and conversion technologies in neuroscience. Nat. Rev. Neurosci. 17, 424–437 (2016).
Israel, M. A. et al. Probing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells. Nature 482, 216–220 (2012).
Tran, J., Anastacio, H. & Bardy, C. Genetic predispositions of Parkinson’s disease revealed in patient-derived brain cells. NPJ Parkinson’s Dis. 6, 8 (2020).
Marchetto, M. C. et al. A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell 143, 527–539 (2010).
Bardy C., Greenberg Z., Perry S. W. & Licinio, J. Personalized Psychiatry (Academic Press, Cambridge, 2020).
Finkbeiner, S., Frumkin, M. & Kassner, P. D. Cell-based screening: extracting meaning from complex data. Neuron 86, 160–174 (2015).
Haston, K. M. & Finkbeiner, S. Clinical trials in a dish: the potential of pluripotent stem cells to develop therapies for neurodegenerative diseases. Annu. Rev. Pharm. Toxicol. 56, 489–510 (2016).
Packer, A. M. et al. Two-photon optogenetics of dendritic spines and neural circuits. Nat. Methods 9, 1202–1205 (2012).
Alivisatos, A. P. et al. Neuroscience: the brain activity map. Science 339, 1284–1285 (2013).
Steinbeck, J. A. et al. Optogenetics enables functional analysis of human embryonic stem cell-derived grafts in a Parkinson’s disease model. Nat. Biotechnol. 33, 204–209 (2015).
Bardy, C., Alonso, M., Bouthour, W. & Lledo, P. M. How, when, and where new inhibitory neurons release neurotransmitters in the adult olfactory bulb. J. Neurosci. 30, 17023–17034 (2010).
Alonso, M. et al. Activation of adult-born neurons facilitates learning and memory. Nat. Neurosci. 15, 897–904 (2012).
Weick, J. P. et al. Functional control of transplantable human ESC-derived neurons via optogenetic targeting. Stem Cells 28, 2008–2016 (2010).
Toni, N. et al. Neurons born in the adult dentate gyrus form functional synapses with target cells. Nat. Neurosci. 11, 901–907 (2008).
Segal, M. Calcium stores regulate excitability in cultured rat hippocampal neurons. J. Neurophysiol. 120, 2694–2705 (2018).
Boyer, L. F., Campbell, B., Larkin, S., Mu, Y. & Gage, F. H. Dopaminergic differentiation of human pluripotent cells. Curr. Protoc. Stem Cell Biol. Chapter 1, Unit1H 6 (2012).
Swistowski, A. et al. Xeno-free defined conditions for culture of human embryonic stem cells, neural stem cells and dopaminergic neurons derived from them. PLoS ONE 4, e6233 (2009).
Liew, C. G., Draper, J. S., Walsh, J., Moore, H. & Andrews, P. W. Transient and stable transgene expression in human embryonic stem cells. Stem Cells 25, 1521–1528 (2007).
Chambers, R. S. & Johnston, S. A. High-level generation of polyclonal antibodies by genetic immunization. Nat. Biotechnol. 21, 1088–1092 (2003).
Birey, F. et al. Assembly of functionally integrated human forebrain spheroids. Nat. 545, 54–59 (2017).
Yoon, S. J. et al. Reliability of human cortical organoid generation. Nat. Methods 16, 75–78 (2019).
Held, P. Using phenol red to assess pH in tissue culture media. BioTek Appl. Note 1, 1–7 (2018).
Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676–682 (2012).
Smith, N. A. et al. Fluorescent Ca(2+) indicators directly inhibit the Na,K-ATPase and disrupt cellular functions. Sci. Signal. 11, eaal2039 (2018).
We thank Mr Sebastian Loskarn and Dr Zarina Greenberg for technical assistance. This work was generously supported by Perpetual Impact Philanthropy, the Brain Foundation, Rebecca L. Cooper Foundation, Ian Potter Foundation, Boileau Corporate Philanthropy, Parkinson’s South Australia, MRFF Australian Government and Department of Health, Australian Research Council LIEF grant (to C.B.); Centre for Nanoscale and Biophotonics (CE140100003), Future fellowship (FT180100565) (to M.R.H.), the US National Research Council Senior Fellow Program to the US Air Force Research Laboratory (to A.M.J.), the Netherlands Organisation for Scientific Research Rubicon Fellowship 019.163LW.032 (to M.vdH.), and the RMIT University Vice-Chancellor’s Research Fellowship (to P.R.) and The Australian Government Research Training Program Scholarship (to M.Z., B.M., and R.A.). Flow cytometry analysis and cell sorting were performed at the South Australian Health Medical Research Institute (SAHMRI) in the ACRF Cellular Imaging and Cytometry Core Facility. The Facility is generously supported by the Detmold Hoopman Group, Australian Cancer Research Foundation and Australian Government through the Zero Childhood Cancer Program.
C.B. is the inventor on the BrainPhys patent. STEMCELL Technologies is distributing the BrainPhys media. K.M., C.M., A.A., L.C., A.H., and E.K. are employees of STEMCELL Technologies. All other authors declare no competing interests.
Peer review information Nature Communications thanks Claire Brown, JeongSeop Rhee and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Peer reviewer reports are available.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Zabolocki, M., McCormack, K., van den Hurk, M. et al. BrainPhys neuronal medium optimized for imaging and optogenetics in vitro. Nat Commun 11, 5550 (2020). https://doi.org/10.1038/s41467-020-19275-x